Gut & MicrobiomeResearch PaperPaywall

Gut Bacteria That Break Down Bile Acids May Protect Metabolic Health in Aging

Aged mice and people with exceptional longevity show more bile acid deconjugation. Boosting it with engineered gut bacteria improved insulin sensitivity in old mice.

Tuesday, November 17, 2026 0 views
Published in Cell Metab
A researcher in a lab coat holding a cage with an aged gray mouse beside lab bench with petri dishes of bacterial cultures

Summary

As we age, our metabolism tends to decline, and the gut microbiome and bile acids are thought to play a role. This study found that older mice had more gut bacterial activity that strips taurine from bile acids, a process called deconjugation, driven by bile salt hydrolase (BSH) enzymes. People with exceptional longevity showed a similar bile acid signature. The researchers then used engineered native gut bacteria to raise BSH activity in aged mice. These mice had better insulin sensitivity, along with supportive changes in body composition and other metabolic measures. The results suggest that the age-related rise in bile acid deconjugation may be protective rather than harmful, as often assumed. This points to microbial bile acid modulation as a possible future strategy for supporting metabolic health in later life, though the work is still preclinical and human interventions have not been tested.

0:00--:--

Detailed Summary

Metabolic health often declines with age, with insulin resistance and unfavorable body composition raising the risk of chronic disease. Interventions such as caloric restriction and time-restricted feeding improve lifespan and metabolic health, partly through the gut microbiome and bile acid signaling. Yet how aging itself changes microbial function and bile acids, and whether this can be used therapeutically, has been unclear.

The researchers examined aged mice and found increased deconjugation of taurine-conjugated bile acids, along with higher transcriptional activity related to bile salt hydrolase (BSH), the microbial enzyme that removes amino acid conjugates from bile acids. They also looked at individuals with exceptional longevity and reported a similar bile acid deconjugation signature, suggesting a link with resilient or exceptional aging.

To test whether this change is helpful, the team used engineered native bacteria to further increase luminal BSH activity in aged mice. This improved insulin sensitivity and was accompanied by supportive changes in body composition and other metabolic readouts.

Together, the findings suggest that elevated BSH activity may play a protective role during aging. They challenge the idea that age-related changes in bile acid biotransformation are uniformly detrimental. Instead, some of these shifts may be adaptive, and amplifying them could offer a new approach to preserving late-life metabolic health through targeted microbiome engineering rather than broad probiotic use.

Several caveats apply. The causal evidence comes from mice, which differ from humans in bile acid composition and microbiome structure. The longevity cohort data are associative and cannot show that deconjugation causes healthy aging. This summary is based on the abstract only, so details on sample sizes, effect magnitudes, sex differences and safety are unavailable. Human trials would be needed before any clinical application.

Key Findings

  • Aged mice showed increased deconjugation of taurine-conjugated bile acids with higher BSH-related transcriptional activity.
  • People with exceptional longevity showed a similar bile acid deconjugation signature, an association with resilient aging.
  • Engineered native bacteria raised luminal BSH activity in aged mice and improved insulin sensitivity.
  • Raising BSH activity also produced supportive changes in body composition and other metabolic readouts.
  • Findings challenge the view that age-related bile acid changes are uniformly harmful.

Methodology

The study combined analyses of aged mice (bile acid profiling and BSH-related transcriptional activity) with comparison to individuals with exceptional longevity. An interventional experiment used engineered native gut bacteria to increase luminal BSH activity in aged mice and measured insulin sensitivity and other metabolic outcomes.

Study Limitations

This summary is based on the abstract only, so sample sizes, effect sizes and statistics are unavailable. Causal evidence comes from mice, and the human longevity data are associative. Authors disclose commercial interests in microbiome companies, and long-term safety of increased BSH activity is untested.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.

Enter your email to subscribe: